StockData
NRC Health logo

NRC Health (NRC) stock

NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3078% above fair value
$25.89−0.44 (-1.69%)

Close on Nov 17, 2026Market cap $572.57MP/E –Yield 2.01%

NRC Health pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

NRC Health's pe ratio was 29.1× on Jan 30, 2026, against 14.8× a year earlier. Over the last 5 years it ranged from 10.9× to 39.1×, with a median of 28.1×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 202629.1×+2.2
2025Dec 31, 202526.8×+11.2
2024Dec 31, 202415.6×−18.5
2023Dec 29, 202334.1×+7.1
2022Dec 30, 202227.0×−2.4
2021Dec 31, 202129.4×−3.2
2019Apr 30, 201932.7×−0.2
2018Dec 31, 201832.8×+24.8
2013Jul 31, 20138.0×−4.2
2012Dec 31, 201212.2×−7.8
2011Jan 31, 201119.9×+0.0
2010Dec 31, 201019.9×–

More NRC Health figures

See a number that looks wrong?